About

Stack Bulletin covers nootropics and cognitive supplements for people who read the ingredient panel before the marketing. We write about dose disclosure, proprietary blends, third-party testing, and the distance between what a study found and what a label implies.

Who writes here

The site is edited by Felix Nourse, a disclosed house pen name maintained by our editorial team — the Economist model, stated openly rather than hidden. Reviews run under the editor's byline; news runs under “Staff, Stack Bulletin.” We publish no fabricated author biographies and claim no credentials we do not have — see the editorial policy for how the bylines work.

How this site is funded

Stack Bulletin is an independent, commercially supported publication. We may earn affiliate or advertising revenue from links on the site. That revenue never dictates our conclusions: scores, pros and cons are editorial judgments, sponsored material is always disclosed with the post, and no verdict can be bought. Commercial enquiries go through the advertise page.

Who this is for

We write for supplement buyers who want the label explained rather than the promise repeated.

How we work

We start at the supplement facts panel. Where a study is cited by a brand, we describe what was actually studied — the compound, the dose, the population, the duration — and say plainly when the product's own dose does not match it. We do not test products in a laboratory and never claim to. Claims we cannot trace to a published source are attributed to the company or cut.

Corrections

If we have published an error — a figure, a date, a term, anything — we want to know. Reach the editorial desk via the contact page. Corrections are the fastest queue we run, and material ones are noted in the post.